Loading
Latest filing published 04 Sept 2026 for Actinium Pharmaceuticals, Inc.. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Sandesh Seth discloses dealings in Actinium Pharmaceuticals, Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 30 December 2016 to 2 September 2026.
The open-market record is one-sided, with 7 purchases worth €45k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants.
In size, the median ticket on the buying side is €4,161.
The newest entry dates from 4 September 2026: a share grant, in Actinium Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,872 days ago, on 10 December 2018. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations